DA
David Amsellem Piper Sandler Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
41
Avg Return
Past Year
Past Year
15%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
65.9%
Neutral
34.1%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Initiated
| $18 |
126%
upside
| 1 | +5.1% |
0
%
| 9 Jan ‘26 10 hours ago |
|
|
|
Overweight
Maintained
| $40 |
25%
upside
| 2 | +23% |
0
%
| 22 Dec ‘25 18 days ago |
|
|
|
Overweight
Reiterated
| $219 |
35%
upside
| 3 | +8.6% |
0
%
| 10 Dec ‘25 1 month ago |
|
|
|
Overweight
Initiated
| $9 |
136%
upside
| 1 | +22% |
0
%
| 25 Nov ‘25 1 month ago |
|
|
|
Neutral
Reiterated
| $157 |
17%
downside
| 3 | – |
–
| 21 Nov ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $381 |
16%
upside
| 5 | +2.5% |
0
%
| 14 Nov ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $8 |
106%
upside
| 1 | -38% |
0
%
| 7 Nov ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $8 |
2%
downside
| 2 | – |
–
| 7 Nov ‘25 2 months ago |
|
|
|
Overweight
Reiterated
| $289 |
30%
upside
| 2 | +5.8% |
0
%
| 5 Nov ‘25 2 months ago |
|
|
|
Overweight
Reiterated
| $41 |
15%
upside
| 2 | +107% |
0
%
| 31 Oct ‘25 2 months ago |
|
|
|
Overweight
Reiterated
| $13 |
1%
downside
| 1 | +31% |
0
%
| 31 Oct ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $179 |
32%
upside
| 3 | +8.1% |
0
%
| 29 Oct ‘25 2 months ago |
|
|
|
Overweight
Reiterated
| $45 |
50%
upside
| 1 | -3.4% |
0
%
| 23 Oct ‘25 2 months ago |
|
|
|
Overweight
Upgraded
| $65 |
26%
upside
| 2 | +7% |
0
%
| 9 Oct ‘25 3 months ago |
|
|
|
Neutral
Maintained
| $25 |
10%
downside
| 3 | – |
–
| 8 Aug ‘25 5 months ago |
|
|
|
Overweight
Maintained
| $121 |
228%
upside
| 3 | -11% |
0
%
| 1 Aug ‘25 5 months ago |
|
|
|
Neutral
Downgraded
| $8.50 |
2%
downside
| 1 | +67% |
–
| 17 Jun ‘25 6 months ago |
|
|
|
Overweight
Maintained
| $18 |
124%
upside
| 1 | -0.87% |
0
%
| 15 May ‘25 7 months ago |
|
|
|
Neutral
Reiterated
| $37 |
20%
downside
| 2 | – |
–
| 9 May ‘25 8 months ago |
|
|
|
Overweight
Initiated
| $65 |
16%
upside
| 1 | +14% |
0
%
| 22 Apr ‘25 8 months ago |
|
|
|
Neutral
Downgraded
| $9 |
6%
downside
| 1 | +1.7% |
–
| 21 Mar ‘25 9 months ago |
|
|
|
Neutral
Reiterated
| $10 |
21%
downside
| 1 | – |
–
| 5 Mar ‘25 10 months ago |
|
|
|
Neutral
Downgraded
| $132 |
0%
upside
| 1 | – |
–
| 14 Jan ‘25 1 year ago |
|
|
|
Overweight
Maintained
| $13 |
40%
downside
| 1 | +101% |
0
%
| 10 Jan ‘25 1 year ago |
|